Aurora Cannabis to Review Takeover Bid From Rival Curaleaf
Aurora Cannabis is reviewing a hostile takeover bid from rival Curaleaf, a move that could reshape the global cannabis market.
5 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 5 separate news trends connected to Cannabis Industry, spanning June 19, 2026 through August 12, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 45 article observations and 40 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
Aurora Cannabis is reviewing a hostile takeover bid from rival Curaleaf, a move that could reshape the global cannabis market.
Pharmaceutical and drug testing industries warn that President Trump's move to reschedule marijuana will lead to increased abuse.
The DEA is facing scrutiny over transparency and witness testimony during hearings regarding the federal rescheduling of marijuana.
The DEA's upcoming marijuana rescheduling hearing is sparking debate and scrutiny across the cannabis industry.
The DEA is facing scrutiny after inviting only opponents of marijuana rescheduling to a hearing scheduled for June 29th.